X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS STERLING BIOTECH DR. DATSONS LABS/
STERLING BIOTECH
 
P/E (TTM) x -10.9 -1.7 - View Chart
P/BV x 0.2 0.1 242.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   STERLING BIOTECH
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
STERLING BIOTECH
Dec-13
DR. DATSONS LABS/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs12611 1,196.2%   
Low Rs313 908.8%   
Sales per share (Unadj.) Rs133.026.8 496.1%  
Earnings per share (Unadj.) Rs0.2-15.0 -1.0%  
Cash flow per share (Unadj.) Rs6.6-5.5 -121.0%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.854.9 234.7%  
Shares outstanding (eoy) m31.66267.87 11.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.3 226.9%   
Avg P/E ratio x516.1-0.5 -111,073.4%  
P/CF ratio (eoy) x11.8-1.3 -930.8%  
Price / Book Value ratio x0.60.1 479.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4771,862 133.1%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m56547 10.2%   
Avg. sales/employee Rs ThNM5,303.3-  
Avg. wages/employee Rs ThNM403.8-  
Avg. net profit/employee Rs ThNM-2,959.0-  
INCOME DATA
Net Sales Rs m4,2117,181 58.6%  
Other income Rs m7943 184.7%   
Total revenues Rs m4,2897,223 59.4%   
Gross profit Rs m569947 60.0%  
Depreciation Rs m2042,543 8.0%   
Interest Rs m4304,377 9.8%   
Profit before tax Rs m13-5,931 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-1,924 -0.3%   
Profit after tax Rs m5-4,007 -0.1%  
Gross profit margin %13.513.2 102.4%  
Effective tax rate %48.032.4 148.0%   
Net profit margin %0.1-55.8 -0.2%  
BALANCE SHEET DATA
Current assets Rs m6,85214,335 47.8%   
Current liabilities Rs m6,71149,809 13.5%   
Net working cap to sales %3.3-494.0 -0.7%  
Current ratio x1.00.3 354.8%  
Inventory Days Days161403 39.9%  
Debtors Days Days318171 186.6%  
Net fixed assets Rs m3,67355,432 6.6%   
Share capital Rs m317268 118.2%   
"Free" reserves Rs m3,76113,935 27.0%   
Net worth Rs m4,07814,701 27.7%   
Long term debt Rs m1,6719,478 17.6%   
Total assets Rs m12,63373,988 17.1%  
Interest coverage x1.0-0.4 -290.0%   
Debt to equity ratio x0.40.6 63.6%  
Sales to assets ratio x0.30.1 343.4%   
Return on assets %3.40.5 687.5%  
Return on equity %0.1-27.3 -0.4%  
Return on capital %7.7-6.4 -119.4%  
Exports to sales %22.925.9 88.4%   
Imports to sales %14.30.2 8,413.9%   
Exports (fob) Rs m9641,860 51.8%   
Imports (cif) Rs m60212 4,933.6%   
Fx inflow Rs m9641,860 51.8%   
Fx outflow Rs m60725 2,439.1%   
Net fx Rs m3571,835 19.5%   
CASH FLOW
From Operations Rs m1,3451,719 78.2%  
From Investments Rs m-2,256-3,148 71.6%  
From Financial Activity Rs m-1,2001,426 -84.1%  
Net Cashflow Rs m-2,111-3 62,079.4%  

Share Holding

Indian Promoters % 4.5 33.9 13.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 1.4 9.9 13.6%  
ADR/GDR % 0.0 16.9 -  
Free float % 94.1 39.3 239.4%  
Shareholders   20,807 21,482 96.9%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   CIPLA  PFIZER  ALKEM LABORATORIES  SHASUN PHARMA  SANOFI INDIA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; IT Stocks Witness Buying Interest(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the IT sector and consumer durables sector witnessing maximum buying interest.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS